Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

Americas

FDA Approves Omvoh by Eli Lilly for Ulcerative Colitis

Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved a new single-injection, once-monthly maintenance option (200 mg/2...

Novartis to Acquire Avidity Biosciences in $12 Billion Deal

Swiss pharmaceutical company Novartis announced that it has reached an agreement to acquire U.S.-based biotechnology firm Avidity Biosciences in a cash deal valued at...

AstraZeneca Unveils Expanded Manufacturing Facility in Texas

AstraZeneca has opened an expanded manufacturing facility in Coppell, Texas, following a $445m investment aimed at meeting growing global demand for its hyperkalaemia therapy,...

FDA Approves Novo Nordisk’s Rybelsus Oral GLP-1 Therapy

Novo Nordisk has announced that the US Food and Drug Administration (FDA) has granted approval for Rybelsus®, the only oral GLP-1 therapy, to reduce...

FDA Approves Amgen and AstraZeneca’s TEZSPIRE for CRSwNP

Amgen and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has granted approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance therapy...

Popular